ArticlePloS one2019

Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).

Andrew J Piper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.